Complete Genomics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (23)

Latest Posts

About This Stock More About This Stock
Race For Coronavirus Vaccine Heats Up: Biotech ETFs To Gain
Article By: Sweta Killa
Wednesday, May 27, 2020 11:34 AM EDT
Given rising spending on drugs and healthcare all over the world, investors should tap the opportune moment by investing in the biotech sector.
In this article: GNOM, IBB, BBH, XBI, BBC, ARKG Also: GSK, MRK, PFE, MRNA
Read
3 Genomics ETFs Worth Jumping For
Article By: Benzinga
Tuesday, May 26, 2020 8:01 PM EDT
The scramble to bring a coronavirus vaccine to market is lifting the health care sector this year as a slew of biotechnology and other, more nuanced exchange-traded funds targeting the group are delivering impressive returns.
In this article: HELX, GNOM, ARKG Also: MRNA
Read
Profit From The Genomics Market Momentum With These ETFs
Article By: Zacks Investment Research
Saturday, May 23, 2020 7:04 PM EDT
It appears that growing demand for personalized medicine, solid investments and higher R&D activities can make genomics the next big thing in the investing space. We highlight a host of ETFs that investors can keep tabs on.
In this article: GSK, GNOM, PBE, ARKG, IDNA
Read
Best June For Stocks In Decades: 5 Best ETFs
Article By: Sweta Killa
Wednesday, June 19, 2019 10:36 PM EDT
While there have been winners in every corner of the space, several ETFs have easily crushed the market by wide margins. Here are five top-performing ETFs so far this month that will continue to outperform if the current trends continue.
In this article: GNOM, PTH, SGDM, SILJ, XLB
Read
Get In On Genomics With This New ETF
Article By: Benzinga
Friday, April 12, 2019 3:30 PM EDT
GNOM enters a crowded segment of the ETF space. With the debut of the Global X fund, there are now almost 20 U.S.-listed biotechnology ETFs, including leveraged funds.
In this article: GNOM Also: VRTX, ILMN, BMRN
Read

PARTNER HEADLINES

Latest Tweets for $GNOM

No tweets yet!